Serum GRB2 was found to be positively correlated with C-reactive protein and interleukin-6 levels, which were higher in patients with T2DM (compared to the healthy population), and further increased in patients with T2DM with carotid atherosclerosis [22]. This evidence concerns the gene GRB2 and type 2 diabetes mellitus.